Pfizer has recommitted to sustained breakthroughs that impact lives positively around the world, just as it recognised influence of patients on every facet of its work.
The Chief Corporate Affairs Officer at Pfizer, Sally Susman, who spoke on the organisation’s yearly global commitment to patients, tagged: “Patients in Focus”, noted that the assurance remains year-round and central to the work it does.
He said in West Africa, they are demonstrating a commitment to patients through an interactive panel discussion with the Country Manager and patient advocates in oncology, rare diseases and immunisation to discuss ‘Promoting Health Equity As a Patient Advocate’. Subair said Pfizer would be able to develop more innovative medicines and breakthroughs when it engages with patients and patient advocacy groups to understand their needs.